Transcription of Public Assessment Report Mutual Recognition …
{{id}} {{{paragraph}}}
Example: air traffic controller
Public Assessment Report Mutual Recognition …
PAR Sayana 104 Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104 SUSPENSION FOR INJECTION UK/H/0960/001/MR UK licence no: PL 00057/0589 Pfizer Limited PAR Sayana 104 Suspension for Injection UK/H/0960/001/MR 2 SAYANA 104 SUSPENSION FOR INJECTION LAY SUMMARY On 9th July 2007, Austria, Belgium, Czech Republic, Germany, Hungary, Ireland, The Netherlands, Norway and Poland granted Marketing Authorisations to Pfizer Limited for the medicinal product Sayana 104 Suspension for Injection. The licences were granted by Mutual Recognition Procedure (MRP), with the UK as Reference Member State (RMS).
PAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
A Procedure for Heavy Menstrual Bleeding, Procedure, NovaSure Endometrial Ablation Summary of Risks, NovaSure ® Endometrial Ablation Summary of Risks, For heavy menstrual bleeding, FDA-Approved Patient Labeling, NEXPLANON, Menstrual bleeding, BLEEDING, Mirena, Mirena for heavy bleeding, Management of Abnormal Uterine Bleeding in, Management of Abnormal Uterine Bleeding in Reproductive, Specialists In Reproductive Medicine & Surgery, CARE OF THE WOMAN UNDERGOING